of blood required for HLA studies from children. Accordingly we performed HLA typing in a group of Indian patients with chronic rheumatic heart disease.
MATERIALS AND METHODS
The control group consisted of 1444 black adults. HLA-A and HLA-B typing was carried out in 59 Indian patients with severe chronic rheumatic heart disease, as defined by the World Health Organization,5) who required cardiac surgery at the Cardiothoracic Surgical Unit, Wentworth Hospital, Durban; HLA-DR and HLA-DQ typing was performed in 58 of these patients. The distribution of valvular lesions was as follows: isolated mitral stenosis, 22 patients mitral stenosis plus aortic incompetence, 1 patient; mitral incompetence and aortic incompetence with aortic stenosis (mixed aortic valve disease), 1 patient; mitral plus aortic incompetence, 5 patients; mitral stenosis with mitral incompetence (mixed mitral valve disease), 16 patients; mixed mitral valve disease plus aortic incompetence, 8 patients; mixed mitral valve disease plus mixed aortic valve disease, 1 patient; isolated aortic incompetence, 5 patients. In each case the rheumatic etiology of the valve lesions was confirmed by inspection of the valve at surgery or on histological examination of the valve. There were 33 female and 26 male patients between 12 and 59 (mean: 32.9) years. The control group consisted of 1444 normal black adults for HLA-A and HLA-B typing, 538 for HLA-DR typing and 370 for HLA-DQ typing. Although over 2000 individual have been tested for the HLA-DR and the HLA-DQ locus in our laboratory, the majority were white or patients with selected diseases.6)
The HLA-A and HLA-B antigens were identified with a 2-stage lymphocytotoxicity test.7) These antigens were identified with 180 antisera, which consisted of local sera which had been requested for use in International Histocompatibility Workshops, local sera that had been verified by use in parallel with International Workshop sera and sera that had been exchanged with other laboratories world wide,8-12) Similarly, 120 sera were used to define the HLA-DR and HLA-DQ antigens in B-cell enriched lymphocyte suspensions prepared with the use of straw packed with nylon wool.13) The difference in the frequency of various antigens between patients and control subjects was tested for significance by means of the chi-square test (without Yates' correction). The resulting p value was multiplied by the number of HLA antigens tested to determine the corrected p value. Relative risk was calculated according to the method of Svejgaard et al.1
RESULTS
The percentages of HLA-A, HLA-B, HLA-DR and HLA-DQ antigens in p=ns for all comparisons patients with chronic rheumatic heart disease and control subjects are shown in Tables I to IV . There was no significant difference in the frequency of the antigens at the A, B, DR and DQ loci between patients and control subjects.
DISCUSSION
Associations between disease and the HLA system may involve class I (HLA-A, B or C) or class II (HLA-DR or HLA-DQ) antigens. In this study, no differences in frequency of any of the HLA-A, B, DR or DQ antigens between Indian patients with chronic rheumatic heart disease and control subjects were found. Our observations confirm our impression obtained from analysis of previous studies1,4,15-26) that no association exists between rheumatic heart disease and any of the antigens at the A or B loci. However, our results with respect to class II antigens are at variance with those we obtained in an earlier study in black patients.4) We had identified an allelic association with rheumatic heart disease in black patients; there was a significantly increased expression of HLA DR1 and HLA DR w6 antigens.4) We were also unable to confirm the findings of workers in India.22,24) One group of workers reported an increased frequency of HLA-DR3 and a decreased frequency of HLA-DR2 in North Indian patients with rheumatic heart disease.
Another team of investigators found a decreased frequency of HLA-DR2 and an increased frequency of HLA-DQw2 in North Indian patients with rheumatic heart disease.24) An increased frequency of HLA-DR2,25) HLA-DR3,26) HLA-DR4,1,23) HLA-DR623) and HLA-DR3 and HLA DR726) antigens has been observed in patients with this disease.
The hypothesis that predisposing genetic factors are important in the development of rheumatic heart disease is not new. From the diversity of findings in published reports on the HLA system in patients with rheumatic heart disease and our present findings it is evident that this hypothesis remains unproven.
